TrialBlood2022

Efficacy and safety of CD19-specific CAR T cell-based therapy in B-cell acute lymphoblastic leukemia patients with CNSL.

Yuekun Qi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.